Administration of Topical Ophthalmic Medication (ATOM): Feasibility of the spraynozzle technique.
Completed
- Conditions
- Ophthalmic drug dispersal.
- Registration Number
- NL-OMON28128
- Lead Sponsor
- Medspray XMEMS BVColosseum 237521 PV Enschedethe Netherlands053 711 28 35info@medspray.nl
- Brief Summary
van Rooij J, Wubbels RJ, de Kruijf WP. A New Spray Device to Deliver Topical Ocular Medication: Penetration of Fluorescein to the Anterior Segment. J Ocul Pharmacol Ther. 2015; 31(9): 531-535. PMID: 26062091
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1. Informed consent;
2. Age > 18 years.
Exclusion Criteria
1. Allergy/hypersensitivity for fluorescein;
2. Previous ocular surgery, including refractive laser surgery;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Autofluorescence of the cornea, anterior chamber, vitreous and retina.
- Secondary Outcome Measures
Name Time Method 1. Treatment satisfaction score (TSS);<br /><br>2. Blinking reflex (qualitative assessment by investigator).